Diego Cortina de la Fuente, MD, M.Sc. in

Diego Cortina de la Fuente, MD, M.Sc.

Sharpshooter · DISC type DC
Director Global Pipeline Value Evidence Strategy (MS, Rare Diseases, Neurodegeneration) at Biogen
📍 Randolph, New Jersey, United States

Diego is a Global Advocacy and Market Access leader with over 15 years of experience maximizing patient access to critical drugs in oncology, hematology, and rare diseases. At Biogen, he leads value and evidence strategy for pipeline assets. He holds an MSc from The London School of Economics and Political Science.

Colleagues describe him as an approachable, empathetic, and results-driven leader. He is known for being a knowledgeable team player, generous with his time, and skilled at formally mentoring others. He is passionate about bringing critical therapies to patients and addressing healthcare inequalities.

For his professional achievements, he was honored for Excellence in Medicine and recognized as a Top Professional by Marquis Whos Who.

Read the full overview →
Experience
16 Years
Current Role
Director Global Pipeline Value Evidence Strategy (MS, Rare Diseases, Neurodegeneration)
Job Level
Mid-senior
Location
Randolph, New Jersey, United States
Personality Overview

How Diego shows up

Fast But Analytical
Rigorous & Demanding
Precise But Practical

They respond well to strong and respectful communication. They like to move fast and expect the same from others. They take a lot of pride in personal achievements.

Priorities

Topics Diego cares about

Patient Access Strategy
His career at Biogen, Novartis, and Bayer has centered on creating pricing and reimbursement strategies to ensure patient access to novel therapies across the globe.
Rare Disease Therapies
His current role at Biogen focuses on shaping the value strategy for pipeline assets in rare diseases, multiple sclerosis, and neurodegeneration.
+5 more topics Login to view topics
Career

Work history

1-2023
Director Global Pipeline Value Evidence Strategy (MS, Rare Diseases, Neurodegeneration)
Biogen
8-2020 - 1-2023
Global Product Development and Commercialization Value and Access lead Fumarates and Interferons
Biogen
2-2016 - 4-2020
Market Access Hematology Franchise Lead - Latin America & Canada
Novartis
1-2011 - 1-2016
Global Advocacy Deputy Director
Bayer Health Care
2-2011 - 11-2013
Regional Market Access Deputy Director Latin America
Bayer Health Care
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2003 - 2004
MSc
The London School of Economics and Political Science (LSE)
2013 - 2014
post Graduate Di
Universidad Anáhuac
Social presence
in
Behavioral profile

DISC profile (public)

D

Dominance (D)

Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.

Other Biogen Employees

Explore more public profiles from related professionals.

RG
Remi Ghandour
Associate Medical Director
Biogen
 Keri Shugrue, MBA
Keri Shugrue, MBA
Head of US Marketing Operations
Biogen
 Erin Spongberg
Erin Spongberg
Senior Manager, Sales and Marketing Operations
Biogen
 Brandon Vassar
Brandon Vassar
Senior Manager, Regulatory Advertising and Promotion
Biogen

More profiles

Discover additional public profiles from our index.

Mark Hazenberg
Mark Hazenberg
Financial controller
Interzorg Noord Nederland
 Maria Ceman
Maria Ceman
Environmental Health and Safety Specialist
MSD Ireland
 Fernando Zuelgaray, MD MBA
Fernando Zuelgaray, MD MBA
Operations Director - Oncology & CMVD
Servier
 Jos Koster
Jos Koster
Financieel controller
Nota Groep
Unlock the full playbookSee exactly how to sell to Diego. Free, 10 seconds.